INNOCAN PHARMA CORPORATION

Insiders InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets 09:30:00 2025-02-07 am EST			5-day change	1st Jan Change
0.1850 ^CAD	+2.78%		+15.62%	-11.90%

Dec. 31	Innocan Pharma Closes Private Placement for $635,444	MT
Dec. 30	InnoCan Pharma Corporation announced that it has received CAD 0.635445 million in funding	CI

Insiders

InnoCan Pharma Corporation Announces Appointment of Dr. Joseph V. Pergolizzi to its Scientific Advisory Board	23-09-15	CI
Innocan Pharma Corporation Announces the Addition of Givi Topchishvili, to Advisory Committee, as A Business Strategy Adviser	22-11-18	CI
InnoCan Pharma Corporation Appoints Roni Kamhi as Chief Operating Officer	22-08-11	CI
Innocan Pharma Corporation Announces Appointment of Dr. Kenji Kitatani to Advisory Committee	22-02-07	CI
Iinnocan Pharma Corporation Announces Addition of Izhar Shay to its Advisory Committee	21-07-14	CI
Innocan Pharma Corporation Appoints Richard Serbin to its Advisory Committee	21-04-06	CI
InnoCan Pharma Corporation Appoints Mitchell Kline to Its Scientific Advisory Committee	21-03-23	CI
Innocan Pharma Corporation Announces Resignation of Bill Macdonald as Member of Board of Directors	20-07-02	CI
InnoCan Pharma Corporation Adds Peter Bloch to Its Board of Directors	20-01-23	CI

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters